-
Document de presse | 2005.04.24
Dengue: we are not all equal in the eyes of this disease
Dengue, a virosis which is raging in tropical areas, is transmitted by mosquitoes. It affects 100 million people each year throughout the world. The genetic analysis of a large cohort of subjects who were hospitalised with this disease in Thailand has enabled researchers at the Institut Pasteur, together with researchers from Inserm (the National Institute for Health and Medical Research), to...
-
Document de presse | 2005.04.18
Newborn susceptibility to infection now deciphered
A joint Institut Pasteur-Inserm team has deciphered key mechanisms in the development of newborn immune systems. This study has made it possible to understand why infants are susceptible to early infections that cause high mortality rates, particularly in developing countries. Understanding these mechanisms offers possibilities for new types of treatment and vaccines adapted to protect newborns...
-
Document de presse | 2005.04.13
The art of camouflaging the parasite responsible for malaria
Researchers from the Institut Pasteur and the CNRS have brought to light the unique mechanisms that allow the parasite responsible for malaria to fool the immune system of those it infects. In collaboration with researchers from the Walter and Eliza Hall Institute of Medical Research of Melbourne, they showed in two articles published in Cell that the parasite is capable of changing the...
-
Document de presse | 2005.02.24
"The Sword and the Shield" - How bacteria develop their virulence by creating multiple variants
Researchers at Institut Pasteur and the French National Institute of Health and Medical Research (Inserm), in association with the Imperial College of London, recently explained why Shigella flexneri bacteria, which cause fatal dysenteries, have several variants (serotypes), thus optimizing their virulence. This discovery, published in Science, is essential to vaccine research as, in order to be...
-
Document de presse | 2005.01.19
The Institut Pasteur retains its rights on an innovative patent
The European Patent Office has confirmed the Institut Pasteur in its rights over an important technology, based on an innovative use of homologous recombination. The European patent, granted as no. 419621, was licensed to the Institut Pasteur's spin-off company, Cellectis. It covers applications in the areas of production of recombinant proteins, gene therapy, and the production of animal...
-
Document de presse | 2005.01.16
Cervical cancer : developing a therapeutic vaccine
A candidate vaccine for treating cervical cancers has just been proven effective in animals by researchers at the Institut Pasteur in cooperation with the French National Health and Medical Research Institute (Inserm) and the French National Center for Scientific Research (CNRS), and by the company BT PHARMA*, an Institut Pasteur start-up company. This therapeutic vaccine is directed against a...
-
Document de presse | 2005.01.10
SouthEast Asia: Institut Pasteur Mobilizes
In response to the risk of epidemics in the regions affected by the disaster, the Institut Pasteur, which is engaged in the battle against infectious diseases on a daily basis, has mobilized. The expert in charge of the Institut Pasteur Emergency Cell for Biological intervention (CIBU) is currently on a mission in Sri Lanka to participate in evaluating the risk of epidemics in this region. At the...
-
Document de presse | 2005.01.05
A candidate Vaccine for West Nile Virus
Researchers at Institut Pasteur recently proved the efficacy of a candidate vaccine against West Nile virus infection in animal model. Their results are published in the Journal of Infectious Diseases. Mosquito-borne West Nile virus is an emerging neurotropic pathogen which is particularly disquieting due to its recent emergence in North America : since 2002, more than 13,000 cases, including 500...
-
Document de presse | 2004.10.10
Inauguration of the Institut Pasteur of Shanghai - Chinese Academy of Sciences
The Institut Pasteur of Shanghai-Chinese Academy of Sciences is being inaugurated today in the presence of Mr. Jacques Chirac, President of the French Republic, Mr. Lu Yongxiang, President of the Chinese Academy of Sciences, Mr. Han Zheng, Mayor of Shanghai, Mr. Philippe Kourilsky, President of the Institut Pasteur, and the Year of France in China's Committee of Honour. Press...
-
Document de presse | 2004.10.03
Legionnaire's disease : genomes of the Paris and Lens strains sequenced
Legionellosis or Legionnaire's disease affected more than 1,000 people in France in 2003 and caused nearly 130 deaths. This emerging disease is caused by Legionella pneumophila, an environmental bacterium that can grow in hot water systems. A team at the Institut Pasteur associated with the CNRS [French National Center for Scientific Research] and in collaboration with the National Reference...
